Health Canada open data (page 15)
Health Canada publishes 2,987 open datasets on CanQuery: 58 with live tables. Preview tables, export CSV and follow original downloads.
- Datasets
- 2987
- Queryable datasets
- 58
- Mappable datasets
- 0
Datasets
- Notice of Amendment: Tramadol removed from the Prescription Drug List (PDL)
- Notice to Stakeholders – Clarification of Requirements under the Food and Drug Regulations and the Controlled Drugs and Substances Act When Conducting Clinical Research with Psilocybin
- Notice to stakeholders: Considerations regarding the proposed use of psilocybin mushrooms in clinical trials, or as a drug accessed through the Special Access Program (SAP)
- Notice to stakeholders: Considerations regarding the proposed use of psilocybin mushrooms in clinical trials, or as a drug accessed through the Special Access Program (SAP)
- Notice to stakeholders: Final guidance document for industry and practitioners on the Special Access Program (SAP) for drugs
- Notice: Clinical trials for medical devices and drugs relating to COVID-19 regulations
- Notice: Confirmation of the Mandatory use of the Regulatory Enrolment Process (REP) as of October 1, 2020
- COVID-19 protein subunit vaccines
- Guidance on applications for COVID-19 drug clinical trials under the Regulations: Overview
- Guidance on applications for COVID-19 drug clinical trials under the Regulations: General requirements
- Guidance on applications for COVID-19 drug clinical trials under the Regulations: Additional requirements
- Guidance on applications for COVID-19 drug clinical trials under the Regulations: Application process
- Guidance on applications for COVID-19 drug clinical trials under the Regulations: Post-authorization requirements
- Clinical Trials Modernization: Consultation Paper
- Comparative Pharmacokinetic Studies for Orally Inhaled Products: Guidance Document
- Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders
- Guidance document - Fees for the right to sell drugs
- Health Product InfoWatch: January 2023
- Health Product InfoWatch: February 2023
- Health Product InfoWatch: March 2023
- Health Product InfoWatch: April 2023
- Health Product InfoWatch: May 2023
- Health Product InfoWatch: June 2023
- Health Product InfoWatch: July 2023
- Health Product InfoWatch: August 2023
- Health Product InfoWatch: September 2022
- Health Product InfoWatch: October 2022
- Health Product InfoWatch: November 2022
- Health Product InfoWatch: December 2022
- Notice: Prescription Drug List (PDL): Multiple Additions (2020-09-08)
- Notice: Prescription Drug List (PDL): Multiple Additions (2020-12-21)
- Health Product InfoWatch: January 2022
- Health Product InfoWatch – February 2022
- Health Product InfoWatch – March 2022
- Health Product InfoWatch: April 2022
- Health Product InfoWatch : May 2022
- Health Product InfoWatch: June 2022
- Health Product InfoWatch – July 2022
- Health Product InfoWatch – August 2022
- Notice of Compliance with conditions (NOC/c)
- Notice of Compliance (NOC) Database
- Notice of Compliance Listings
- Notice of compliance (NOCC) database Frequently Asked Questions
- Notice of Compliance (NOC) Data Extract
- Post-Notice of Compliance changes: Guidance for safety and efficacy of veterinary drugs: Overview
- Post-Notice of Compliance changes: Guidance for safety and efficacy of veterinary drugs: Documentation
- Post-Notice of Compliance changes: Guidance for safety and efficacy of veterinary drugs: Reporting categories
- Rozlytrek - Notice of Compliance with Conditions - Qualifying Notice
- Summary: Guidance Document - Post-Notice of Compliance (NOC) Changes: Framework Document (Pharmaceutical, biologic and radiopharmaceutical drugs for human use only)
- Summary: Guidance Document- Post-Notice of Compliance (NOC) Changes: Safety and Efficacy